Most people know about type 1 and type 2 diabetes, but there are at least five well-recognized forms, plus several rarer genetic subtypes. The American Diabetes Association’s current standards of care classify diabetes into four main categories: type 1, type 2, gestational diabetes, and “specific types due to other causes,” a broad group that includes genetic forms, pancreatic disease, and more. In practice, that fourth category contains enough distinct conditions that the real number of diabetes types is closer to a dozen, depending on how you count.
Type 1 Diabetes
Type 1 diabetes is an autoimmune condition. Your immune system attacks the cells in the pancreas that produce insulin, eventually destroying them almost entirely. Without insulin, glucose builds up in the blood instead of entering cells for energy. People with type 1 need insulin from the day of diagnosis, whether through injections or a pump, and that never changes.
Type 1 is most commonly diagnosed in children and teenagers, but it can appear at any age. Diagnosis now often involves testing for specific autoantibodies, proteins in the blood that signal the immune attack is underway. These antibody tests help distinguish type 1 from type 2, which matters because the two require very different treatment.
Type 2 Diabetes
Type 2 is by far the most common form, accounting for roughly 90 to 95 percent of all diabetes cases. It develops when your body becomes resistant to insulin or when your pancreas gradually loses the ability to make enough. Unlike type 1, it usually comes on slowly over years and is strongly linked to weight, inactivity, and genetics.
Many people with type 2 manage it initially through diet, exercise, and oral medications. Some eventually need insulin as the disease progresses, but not all do. A fasting blood sugar of 126 mg/dL or higher, an A1C of 6.5% or above, or a two-hour glucose reading of 200 mg/dL or more on an oral glucose tolerance test all meet the diagnostic threshold. Below those numbers but above normal (an A1C between 5.7% and 6.4%, for instance) is considered prediabetes, a stage where lifestyle changes can sometimes prevent or delay the full condition.
Gestational Diabetes
Gestational diabetes develops during pregnancy, typically in the second or third trimester. Hormonal changes make cells more resistant to insulin, and some women’s pancreases can’t compensate. It usually resolves after delivery, but it significantly raises the risk of developing type 2 diabetes later in life.
Screening uses a glucose tolerance test with its own set of cutoffs. In the one-step version, a fasting level of 92 mg/dL, a one-hour reading of 180 mg/dL, or a two-hour reading of 153 mg/dL flags a diagnosis. Meeting just one of those thresholds is enough. Managing gestational diabetes typically involves blood sugar monitoring, dietary adjustments, and sometimes insulin to protect both the mother and baby.
LADA: The “In-Between” Type
Latent autoimmune diabetes in adults, or LADA, is sometimes called type 1.5 because it shares features of both major types. Like type 1, it involves autoimmune destruction of insulin-producing cells, confirmed by the same kinds of autoantibodies (particularly one called GAD65). Like type 2, it appears in adulthood, generally after age 30, and progresses slowly enough that people don’t need insulin right away.
That slow onset is what makes LADA tricky. Many people with LADA are initially told they have type 2 diabetes. Clues that suggest LADA instead include a lean or normal body weight, diagnosis before age 50, a personal or family history of autoimmune conditions, and the ability to go at least six months after diagnosis without needing insulin. Eventually, though, insulin-producing cells decline to the point where insulin therapy becomes necessary. Recognizing LADA early matters because the treatment path differs from standard type 2 management.
Type 3c: Diabetes From Pancreatic Damage
Type 3c diabetes, also called pancreatogenic diabetes, develops when the pancreas is physically damaged by disease, injury, or surgery. Chronic pancreatitis is the most common trigger, but acute pancreatitis, pancreatic cancer, cystic fibrosis, iron overload (hemochromatosis), and surgical removal of part or all of the pancreas can all cause it. Estimates suggest type 3c accounts for 1% to 9% of all diabetes cases, a wide range partly because it’s frequently misdiagnosed as type 2.
What makes type 3c distinct is that the damage isn’t limited to insulin production. The pancreas also produces digestive enzymes, so people with type 3c often deal with digestive problems alongside blood sugar issues. Treatment addresses both sides: insulin to manage glucose plus enzyme supplements to help with digestion.
MODY: Diabetes Caused by a Single Gene
Maturity-onset diabetes of the young, or MODY, is a group of genetic forms caused by a mutation in a single gene passed down through families. It accounts for a small percentage of all diabetes cases but is important to identify because each subtype behaves differently and responds to different treatments.
The most common form, caused by a mutation in the HNF1A gene, makes up 50 to 70 percent of MODY cases and typically responds well to a class of oral medication rather than insulin. The second most common, caused by a GCK gene mutation, produces mildly elevated blood sugar that’s stable over a lifetime and often needs no treatment at all. Less common subtypes involve mutations in the HNF4A and HNF1B genes, each accounting for 5 to 10 percent of cases. There are at least 14 identified MODY subtypes in total, though most are exceedingly rare.
MODY is often mistaken for type 1 or type 2 because doctors aren’t always looking for it. Red flags include a strong family history of diabetes across multiple generations, diagnosis in adolescence or early adulthood, and an absence of the autoantibodies seen in type 1 or the insulin resistance typical of type 2. Genetic testing confirms the diagnosis.
Neonatal Diabetes
Neonatal diabetes appears within the first six months of life and is caused by genetic mutations affecting how the pancreas produces or releases insulin. It comes in two forms: permanent and transient. The permanent form lasts a lifetime, while the transient form resolves in infancy but can reappear later.
About 25 percent of permanent cases stem from a mutation in the KCNJ11 gene, which controls a channel in insulin-producing cells. Another 20 to 25 percent involve the INS gene, which carries the instructions for making insulin itself. An additional 10 to 15 percent are linked to the ABCC8 gene. Identifying the specific mutation matters because some children with KCNJ11 or ABCC8 mutations can switch from insulin injections to an oral medication, a dramatic quality-of-life improvement.
Rare Syndromic Forms
Several rare genetic syndromes include diabetes as one of multiple features. Wolfram syndrome combines diabetes with vision loss, hearing loss, and a form of diabetes insipidus (a separate condition involving water balance, not blood sugar). Because high blood sugar sometimes appears first, Wolfram syndrome can initially look like ordinary type 1 before the other symptoms emerge.
Donohue syndrome and its milder relative, Rabson-Mendenhall syndrome, result from mutations in the insulin receptor gene, making the body severely resistant to insulin from birth. Alström syndrome causes diabetes alongside obesity, vision and hearing problems, and heart issues. These conditions are all very rare, but they illustrate how many distinct biological pathways can lead to diabetes.
Why the Exact Count Matters Less Than the Right Diagnosis
If you tally the ADA’s four broad categories, you get four. If you count the clinically distinct forms within those categories, you’re easily above ten. Add in every known MODY subtype and rare syndrome, and the number climbs further. The exact count depends on where you draw the line between a “type” and a “subtype.”
What matters more than the number is getting the right label. Someone with LADA who’s treated as a standard type 2 patient may not get insulin soon enough. Someone with GCK-MODY may take medication for years that they never needed. The expanding recognition of diabetes subtypes is pushing medicine toward more precise matching of treatment to the specific form a person actually has.